| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/24/2006 | CN1777596A Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 05/24/2006 | CN1777592A Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives |
| 05/24/2006 | CN1777590A Indazole derivatives |
| 05/24/2006 | CN1777584A (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht 1f agonists |
| 05/24/2006 | CN1777582A Substituted indoline and indole derivatives |
| 05/24/2006 | CN1777427A Aminoheteroaryl compounds as protein kinase inhibitors |
| 05/24/2006 | CN1777423A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/24/2006 | CN1775762A Liyustrazine acyl piperazine derivative, and its preparing method and medicinal composition and use |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1775752A Optical pure diamide compound and its use |
| 05/24/2006 | CN1775738A Arylamine hole transport material using binaphthalene as backbone and its synthesizing method |
| 05/24/2006 | CN1257166C Process for preparing tricyclic compound having antihistaminic activity |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 05/23/2006 | US7049442 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins |
| 05/23/2006 | US7049440 Chemical intermediate for tricyclic compound |
| 05/23/2006 | US7049438 Quinazoline derivatives for treatment of tumours |
| 05/23/2006 | US7049343 Nitrogen compounds such as 3-(N'-(2,6-dinitro-4-trifluoro methylphenyl)-N-(3-methoxyphenylhydrazino)propionic acid, used as glycine transport antagonists for prophylaxis of psychological disorders |
| 05/23/2006 | US7049333 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049323 Amidoheterocycles as modulators of the melanocortin-4 receptor |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049318 1-Benzyl-2-(5-benzylamino-1-methyl-6-oxo-4-pyridin-4-yl-1,6-dihydro-pyrimidin-2-ylamino)-ethyl]-(S)-carbamic acid tert-butyl ester or derivatives |
| 05/23/2006 | US7049316 Prodrugs of CC-1065 analogs |
| 05/23/2006 | US7049310 Therapy for bacteria infections |
| 05/23/2006 | US7049309 Administering a therapeutically effective amount of 3-thia-4-(2-oxy/hydroxyphenyl)quinolin-2-one derivative to a patient to treat erectile dysfunction or irritable bowel syndrome |
| 05/23/2006 | US7049307 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | CA2257200C Substituted imidazoles having cytokine inhibitory activity |
| 05/23/2006 | CA2242494C Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
| 05/23/2006 | CA2158454C Taxanes having furyl or thienyl substituted side-chain |
| 05/18/2006 | WO2006053112A1 Process for preparing trisubstituted pyrimidine compounds |
| 05/18/2006 | WO2006053109A1 Heteroaryl compounds |
| 05/18/2006 | WO2006052378A1 Constrained compounds as cgrp-receptor antagonists |
| 05/18/2006 | WO2006052190A1 Indazole sulphonamide derivatives |
| 05/18/2006 | WO2006052189A1 Nitro indazole derivatives |
| 05/18/2006 | WO2006051891A1 Production method of pyrimidine compounds |
| 05/18/2006 | WO2006051851A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
| 05/18/2006 | WO2006051806A1 Metal complex compound and organic electroluminescent device using same |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006051399A1 Piperazine derivatives useful as adrenergic receptor antagonists |
| 05/18/2006 | WO2006051374A2 Arylpiperazines useful as adrenergic receptor antagonists |
| 05/18/2006 | WO2006051311A1 Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes |
| 05/18/2006 | WO2006051290A2 Compounds for treating protein-kinase mediated disorders |
| 05/18/2006 | WO2006050992A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 05/18/2006 | WO2006050989A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 05/18/2006 | WO2006050964A2 Indinavir derivatives useful in immunoassay |
| 05/18/2006 | WO2006050772A1 Vinylaminopyrazole derivatives as pesticides |
| 05/18/2006 | WO2006050598A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 05/18/2006 | WO2006038006A3 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 05/18/2006 | WO2006034480A3 Sulfonamide bicyclic compounds |
| 05/18/2006 | WO2006023931A3 Kinase inhibitors |
| 05/18/2006 | WO2006021881A3 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 05/18/2006 | WO2006012504A3 Compounds and methods for treatment of thrombosis |
| 05/18/2006 | WO2006010446A3 Medicinal use of receptor ligands |
| 05/18/2006 | WO2005095379A3 Crystalline methanesulfonic acid addition salts of imatinib |
| 05/18/2006 | WO2005086871A3 Compounds, compositions and methods for inhibiting or treating hiv-1 |
| 05/18/2006 | WO2005082884A3 2-pyridin-2yl-pyrimidine derivatives useful in the treatment of gastro-esophagea l reflux disease |
| 05/18/2006 | WO2005068074A3 Use of metal complex compounds comprising pyridine pryimidine or s-triazne derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acid and h2o2 |
| 05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 05/18/2006 | WO2005032484A9 Alkoxy substituted imidazoquinolines |
| 05/18/2006 | US20060106225 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106069 4-(5-Chloro-2-isopropylaminopyridin-4-yl)-1-(toluene-4-sulfonyl)-1H-pyrrole-2-carboxylic acid methyl ester; mitogen-activated protein kinase inhibitor; antiproliferative, anticarcinogenic agent; study of intracellular signal transduction pathways; evaluation of new kinase inhibitors |
| 05/18/2006 | US20060106066 Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives |
| 05/18/2006 | US20060106062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
| 05/18/2006 | US20060106061 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/18/2006 | US20060106059 Melanocortin receptor ligands |
| 05/18/2006 | US20060106058 Chemical compounds |
| 05/18/2006 | US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders |
| 05/18/2006 | US20060106042 Substituted heterocyclpyrmidines |
| 05/18/2006 | US20060106026 4-(4-methylpiperazin-1-ylmethyl)-n-[4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating anaplastic thyroid cancer |
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/18/2006 | US20060105927 Colorant compositions |
| 05/18/2006 | US20060105445 Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins |
| 05/18/2006 | US20060105416 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2586702A1 Vinylaminopyrazole derivatives as pesticides |
| 05/18/2006 | CA2585546A1 Indinavir derivatives useful in immunoassay |
| 05/18/2006 | CA2585490A1 Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes |
| 05/18/2006 | CA2585165A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 05/17/2006 | EP1657241A1 Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
| 05/17/2006 | EP1657240A1 Pyridyltetrahydropyridines, pyridylpiperidines, and process for the production of both |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1656940A1 Angiotensin II receptor antagonists for treating vascular headache conditions |
| 05/17/2006 | EP1656373A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokineantagonists |
| 05/17/2006 | EP1656367A1 4- (heterocyclyl- fused phenyl)- 3- (phenyl or pyrid -2- yl) pyrazoles as inhibitors of the alk-5- receptor |
| 05/17/2006 | EP1656366A1 Substituted pyrimdinone derivatives and methods of use |
| 05/17/2006 | EP1656365A1 A method for the preparation of enantiomerically pure mirtazapine |
| 05/17/2006 | EP1656355A2 Piperazine derivatives and methods of use |
| 05/17/2006 | EP1656353A1 Gabanergic modulators |
| 05/17/2006 | EP1656350A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 05/17/2006 | EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 05/17/2006 | EP1656346A1 Novel substituted 3-sulfur indoles |
| 05/17/2006 | EP1656345A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656141A1 Treatment for alzheimer s disease and related conditions |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656132A2 Novel pyrrole-based hmg-coa reductase inhibitors |
| 05/17/2006 | EP1656096A2 Methods of reducing risk of infection from pathogens |